Cartesian Therapeutics, Inc. Other Expenses
Cartesian Therapeutics, Inc. (RNAC) reported Other Expenses of $64.00 thousand for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherExpenses · last filed 2016-08-09
- Cartesian Therapeutics, Inc. other expenses for the quarter ending 2016-06-30 was $64.00K, a 72.97% increase year-over-year.
- Cartesian Therapeutics, Inc. other expenses for the quarter ending 2015-06-30 was $37.00K.
| Period end | Other Expenses 3 month | Other Expenses 6 month |
|---|---|---|
| 2016-06-30 | $64.00K 10-Q · filed 2016-08-09 | $82.00K 10-Q · filed 2016-08-09 |
| 2015-06-30 | $37.00K 10-Q · filed 2016-08-09 | $37.00K 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |